Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 514 M537 M525 M558 M611 M 2.23 B Research & development 377 M394 M375 M390 M437 M 1.6 B Operating income 203 M291 M343 M631 M382 M 1.65 B Non-Operating Income, Total -973 M788 M-35 M261 M-1.02 B -2 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -973 M788 M-35 M261 M-1.02 B -2 M Unusual income/expense ————— — Pretax income -793 M1.05 B287 M1.54 B-655 M 2.22 B Equity in earnings -23 M-24 M-21 M28 M-21 M -38 M Taxes -88 M173 M44 M149 M-53 M 313 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -682 M906 M264 M743 M-581 M 1.33 B Discontinued operations ————— — Net income -682 M906 M264 M743 M-581 M 1.33 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -682 M906 M264 M743 M-581 M 1.33 B Basic earnings per share (Basic EPS) -0.530.70.20.58-0.45 1.03 Diluted earnings per share (Diluted EPS) -0.530.690.20.58-0.45 1.02 Average basic shares outstanding 1.3 B1.3 B1.3 B1.3 B1.3 B — Diluted shares outstanding 1.3 B1.31 B1.31 B1.3 B1.3 B — EBITDA 211 M299 M351 M638 M389 M 1.68 B EBIT 203 M291 M343 M631 M382 M 1.65 B Cost of revenue 1.19 B1.38 B1.45 B1.98 B1.62 B 6.43 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 8 M8 M8 M7 M7 M 30 M